Biotechnology Stocks I: Returns for Protagonist Therapeutics, Inc. (PTGX)
PTGX has no dividends.
Table and Chart of PTGX Performance
See what a $1,000 investment in PTGX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PTGX Returns | |
|---|---|
| Start Date | Sep-30-2016 |
| Start Price | $21.13 |
| End Date | Dec-05-2024 |
| End Price | $41.68 |
| # Prices | 100 |
| Min Date | Nov-30-2018 |
| Min Price | $6.47 |
| Max Date | Jul-30-2021 |
| Max Price | $49.43 |
| Total Return | 97.26% |
| Annualized Return | 8.49% |
| Current Value of $1,000 Purchase | $1,973 |
| Number Returns | 4,950 |
| Average Return | 76.09% |
| Number Profitable Returns | 3,273 |
| Percent Profitable Returns | 66.12% |
| Number Unprofitable Returns | 1,677 |
| Percent Unprofitable Returns | 33.88% |
| Profitable to Unprofitable Returns Ratio | 1.95 |
| PTGX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 13.140 | Price to Sales | 666.67 |
| Earnings per Share | $0.0000 |
| PE Ratio | 150068000 |
| PE to Growth Ratio | 15.09 |
| Price to Book | 7.47 |
| PRICE DATA | |
| 52 Week High | $2.163 |
| 52 Week Low | $48.89 |
| Analyst Target Price | $-1 |
| 50-Day Moving Average | $19 |
| 200-Day Moving Average | $45.02 |
| FINANCIAL DATA | |
| Revenue per Share | $2.69 |
| Revenue | $0 |
| Profit Margin | 530% |
| Return on Equity | 20% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PTGX Compare Returns with S&P 500
PTGX Trendline Chart
PTGX Moving Average Chart
PTGX Stock Return Map - See Patterns of Gains and Losses
PTGX Stock Returns/Purchase Dates